The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Predictive biomarkers for pathological complete response in early-stage triple negative breast cancer following neoadjuvant chemotherapy.
 
Gabriel Berlingieri Polho
No Relationships to Disclose
 
Laura Testa
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Daiichi Sankyo/Astra Zeneca; Daiichi Sankyo/Astra Zeneca; Lilly; Lilly; MSD Oncology; MSD Oncology; MSD/AstraZeneca; Novartis; Pfizer
Speakers' Bureau - Daiichi Sankyo/Astra Zeneca; Lilly; MSD Oncology; Novartis; Pfizer
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Gilead Sciences; Roche
 
ROMUALDO BARROSO-SOUSA
Consulting or Advisory Role - AstraZeneca; AstraZeneca/Daiichi Sankyo; AstraZeneca/Merck; Libbs; Lilly; MSD; Novartis; Pfizer; Roche
Speakers' Bureau - AstraZeneca/Daiichi Sankyo; Libbs; Lilly; MSD; Novartis; Pfizer; Roche
Research Funding - AstraZeneca/Daiichi Sankyo; Roche
Travel, Accommodations, Expenses - AstraZeneca/Daiichi Sankyo; AstraZeneca/Daiichi Sankyo; Gilead Sciences; MSD
 
Renata Colombo Bonadio
Consulting or Advisory Role - MSD
Speakers' Bureau - Adium Pharma; AstraZeneca; BMS Brazil; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; MSD; Nestle health science; Pfizer
Research Funding - AstraZeneca (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Daiichi Sankyo/Astra Zeneca; MSD; MSD